Schutte, Tim http://orcid.org/0000-0002-4096-0917
Stege, Claudia A. M.
Smits, Mark M.
Franssen, Laurens E.
Donker, Marjolein L.
de Leeuw, David C.
Article History
Accepted: 26 July 2022
First Online: 10 August 2022
Declarations
:
: The authors report no funding and received no financial support for the research, authorship, and/or publication of this article.
: Tim Schutte, Claudia Stege, Mark Smits, Laurens Franssen and Marjolein Donker have no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. David de Leeuw is on the Advisory board of Takeda and Servier; has received honoraria for speaking at symposia from Roche, Servier, and AbbVie.
: Ethics Committee or institutional review board approval was not applicable for this retrospective case report with individual patient consent.
: The patient described in this case report consented to be described in a case report and provided informed consent.
: The patient described in this case report consented to publication of a report detailing his case, including images of his scans, laboratory studies, and results of the EUS-guided FNA.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Tim Schutte: Patient care, draft manuscript, and corresponding author. Claudia Stege: Patient care and revision of manuscript. Mark Smits: Patient care and revision of manuscript. Laurens Franssen: Patient care, supervision of patient care, and revision of manuscript. Marjolein Donker: Patient care, supervision of patient care, and revision of manuscript. David de Leeuw: Patient care, supervision of patient care, and revision of manuscript. All authors provided substantial contributions to the paper and consent to the publication of this article.
Free to read: This content has been made available to all.